State Street’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-1,616,058
| Closed | -$28.7M | – | 3812 |
|
2018
Q3 | $28.7M | Buy |
1,616,058
+48,436
| +3% | +$860K | ﹤0.01% | 1925 |
|
2018
Q2 | $21.6M | Buy |
1,567,622
+1,518,043
| +3,062% | +$20.9M | ﹤0.01% | 2086 |
|
2018
Q1 | $451K | Buy |
49,579
+32,500
| +190% | +$296K | ﹤0.01% | 3448 |
|
2017
Q4 | $72K | Hold |
17,079
| – | – | ﹤0.01% | 3624 |
|
2017
Q3 | $24K | Sell |
17,079
-500
| -3% | -$703 | ﹤0.01% | 3711 |
|
2017
Q2 | $27K | Sell |
17,579
-623,897
| -97% | -$958K | ﹤0.01% | 3641 |
|
2017
Q1 | $1.65M | Buy |
641,476
+21,228
| +3% | +$54.6K | ﹤0.01% | 3147 |
|
2016
Q4 | $1.58M | Buy |
620,248
+16,289
| +3% | +$41.5K | ﹤0.01% | 3179 |
|
2016
Q3 | $1.87M | Buy |
603,959
+6,234
| +1% | +$19.3K | ﹤0.01% | 2992 |
|
2016
Q2 | $1.92M | Sell |
597,725
-1,163
| -0.2% | -$3.74K | ﹤0.01% | 3044 |
|
2016
Q1 | $1.86M | Sell |
598,888
-196,616
| -25% | -$611K | ﹤0.01% | 3028 |
|
2015
Q4 | $3.19M | Buy |
795,504
+13,444
| +2% | +$53.9K | ﹤0.01% | 2782 |
|
2015
Q3 | $3.58M | Buy |
782,060
+8,392
| +1% | +$38.4K | ﹤0.01% | 2685 |
|
2015
Q2 | $4.02M | Buy |
773,668
+32,724
| +4% | +$170K | ﹤0.01% | 2744 |
|
2015
Q1 | $4.64M | Buy |
740,944
+153,369
| +26% | +$960K | ﹤0.01% | 2602 |
|
2014
Q4 | $3.7M | Sell |
587,575
-2,536
| -0.4% | -$16K | ﹤0.01% | 2729 |
|
2014
Q3 | $3.59M | Sell |
590,111
-15,563
| -3% | -$94.6K | ﹤0.01% | 2714 |
|
2014
Q2 | $3.99M | Buy |
605,674
+98,259
| +19% | +$648K | ﹤0.01% | 2720 |
|
2014
Q1 | $12.1M | Sell |
507,415
-636
| -0.1% | -$15.1K | ﹤0.01% | 2101 |
|
2013
Q4 | $5.43M | Sell |
508,051
-5,656
| -1% | -$60.5K | ﹤0.01% | 2536 |
|
2013
Q3 | $6.85M | Buy |
513,707
+2,504
| +0.5% | +$33.4K | ﹤0.01% | 2340 |
|
2013
Q2 | $6.71M | Buy |
+511,203
| New | +$6.71M | ﹤0.01% | 2287 |
|